ARTICLE | Clinical News
Vfend voriconazole regulatory update
December 17, 2001 8:00 AM UTC
Europe's Committee for Proprietary Medicinal Products (CPMP) recommended approval of PFE's Vfend to treat invasive aspergillosis and invasive infections due to candida, scedosporium and fusarium speci...